Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use
AACN Advanced Critical Care · 15.03.2026 · 37 (1) · 6-14
DOI: 10.4037/aacnacc2026442 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACN Advanced Critical Care, erschienen am 15.03.2026. Verfasst von Gwang-Yee Jessica Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gwang-Yee Jessica Hu is Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, t…. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Gwang-Yee Jessica Hu is Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, 160 Frelinghuysen Rd, Piscataway, N…
- Niti Shah is Clinical Pharmacist, Critical Care, Department of Pharmacy, Morristown Medical Center, Atlantic Health System, Morristown, New Jersey.
Zitieren
APA
Hu, G. J., & Shah, N. (2026). Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use. AACN Advanced Critical Care, 37(1), 6-14. https://doi.org/10.4037/aacnacc2026442
Vancouver
Hu GJ, Shah N. Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use. AACN Advanced Critical Care. 2026;37(1):6-14. doi:10.4037/aacnacc2026442
BibTeX
@article{Hu2026,
author = {Hu, Gwang-Yee Jessica and Shah, Niti},
title = {Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use},
journal = {AACN Advanced Critical Care},
year = {2026},
volume = {37},
number = {1},
pages = {6--14},
doi = {10.4037/aacnacc2026442}
}
EUVIMED